Recombinant Human C8orf33 Protein: Handling & Usage Protocol

Recombinant Human C8orf33 Protein is a research-grade recombinant protein requiring careful reconstitution, controlled storage, and optimized handling procedures to maintain its integrity and ensure reproducible performance across downstream biochemical and cell-based assays.

Product Name

Recombinant Human C8orf33 Protein

SKU

rp375832

Species

Human (Homo sapiens)

Protein Type

Recombinant protein

Recommended Storage

-20°C or -80°C; avoid repeated freeze-thaw cycles

Primary Applications

Biochemical assays, functional studies, protein interaction studies

Materials and Equipment Required

Before beginning, ensure the following materials and equipment are available in your laboratory:

• Recombinant Human C8orf33 Protein (SKU: rp375832, Aladdin Scientific)
• Sterile, nuclease-free water or appropriate reconstitution buffer (e.g., PBS, pH 7.4, or as specified in the product datasheet)
• Microcentrifuge tubes (low-protein-binding, 1.5 mL)
• Calibrated micropipettes and sterile filtered tips
• Vortex mixer and benchtop microcentrifuge
• Ice bucket or cooling block
• -20°C and/or -80°C freezer for long-term storage
• Protein quantification reagents (e.g., BCA or Bradford assay kit) if concentration verification is required

Note: Always work on ice when handling reconstituted protein to minimize activity loss. Consult the product datasheet supplied with SKU rp375832 for any product-specific buffer recommendations.

Reconstitution Procedure

Follow these steps to properly reconstitute Recombinant Human C8orf33 Protein:

1. Equilibrate the vial: Remove the lyophilized protein vial from the freezer and allow it to equilibrate to room temperature for 5–10 minutes before opening. This reduces condensation and minimizes protein aggregation risk.
2. Brief centrifugation: Briefly centrifuge the sealed vial (1,000–2,000 × g, 30 seconds) to collect any lyophilized material that may have adhered to the cap or sides of the vial.
3. Add reconstitution buffer: Add the appropriate volume of sterile reconstitution buffer (as specified on the product datasheet for rp375832) slowly and dropwise along the inner wall of the vial. Do not pipette directly onto the lyophilized cake to avoid foaming or denaturation.
4. Gentle dissolution: Gently swirl or pipette the solution carefully to dissolve the protein. Do not vortex vigorously. Allow the solution to stand on ice for 5 minutes if dissolution is incomplete.
5. Final centrifugation: Centrifuge the reconstituted solution briefly (5,000 × g, 1 minute, 4°C) to remove any insoluble particulates.
6. Protein quantification (optional): If required, determine the protein concentration using a BCA or Bradford assay, comparing against a BSA standard curve.

Important: Consult the specific datasheet for rp375832 to confirm the recommended reconstitution volume and buffer composition prior to proceeding.

Storage and Stability Guidelines

Proper storage is critical to maintaining the activity and integrity of Recombinant Human C8orf33 Protein over time. Adhere to the following guidelines:

• Lyophilized (unopened): Store at -20°C or -80°C, protected from light and moisture. Under these conditions, the lyophilized protein is stable for an extended period as specified on the product datasheet.
• Reconstituted protein (short-term): Store at 4°C for up to 48–72 hours if the protein will be used within this timeframe. Add a carrier protein (e.g., 0.1% BSA) if recommended by the datasheet to enhance stability.
• Reconstituted protein (long-term): Aliquot the reconstituted protein into single-use volumes using low-protein-binding microcentrifuge tubes to avoid repeated freeze-thaw cycles. Store aliquots at -20°C or -80°C.
• Freeze-thaw cycles: Minimize freeze-thaw cycles to no more than 2–3 cycles total. Repeated freeze-thaw significantly reduces protein activity and may cause aggregation.
• Do not store in frost-free freezers: Temperature fluctuations in frost-free freezers can accelerate protein degradation.

Note: Always verify specific stability data from the rp375832 product datasheet, as storage recommendations may vary based on formulation.

Experimental Application Guidelines

Recombinant Human C8orf33 Protein (rp375832) is intended for research use only. The following general guidance applies to its use in downstream assays:

• Working concentration: Optimal working concentrations should be determined empirically for each specific assay system. Perform a dose-response or titration experiment to identify the minimum effective concentration that produces a reproducible signal or biological response.
• Assay compatibility: This recombinant protein may be suitable for applications including biochemical binding assays, protein–protein interaction studies, enzyme activity assays (if applicable), and cell-based functional studies. Confirm suitability for your specific application by referencing validated application data on the product datasheet.
• Carrier protein: When diluting to low concentrations (typically below 10 µg/mL), consider adding a carrier protein such as 0.1% BSA (IgG-free, protease-free) to minimize non-specific adsorption to tube surfaces.
• Endotoxin awareness: For cell-based assays, verify the endotoxin level of the protein lot prior to use, as endotoxin contamination can confound biological results. Consult the Certificate of Analysis (CoA) for rp375832.
• Controls: Always include appropriate positive and negative controls in each experiment to validate assay performance and ensure data integrity.

Troubleshooting

If unexpected results are obtained when working with Recombinant Human C8orf33 Protein, consider the following troubleshooting points:

Issue	Possible Cause	Suggested Action
No detectable signal in assay	Protein activity lost due to improper storage or excessive freeze-thaw	Use a freshly prepared aliquot; verify storage conditions and freeze-thaw history
Protein aggregation or precipitation	Reconstitution buffer incompatibility or protein concentration too high	Centrifuge briefly before use; reduce concentration or change buffer; add carrier protein
High background or non-specific binding	Endotoxin contamination or insufficient blocking	Verify endotoxin levels via CoA; increase blocking agent concentration
Irreproducible results between experiments	Inconsistent working concentration or pipetting error	Prepare fresh dilutions each experiment; use calibrated pipettes; verify protein concentration by BCA/Bradford
Protein not fully dissolved after reconstitution	Insufficient buffer volume or vigorous vortexing causing aggregation	Add additional buffer; gently swirl; incubate on ice for additional time

Frequently asked questions

What is the recommended reconstitution buffer for Recombinant Human C8orf33 Protein (rp375832)?

The recommended reconstitution buffer and volume are specified on the product datasheet and Certificate of Analysis (CoA) supplied with SKU rp375832. In general, sterile PBS (pH 7.4) supplemented with a carrier protein such as 0.1% BSA is commonly used for recombinant proteins, but you should always confirm with the specific product documentation before proceeding.

How many freeze-thaw cycles can Recombinant Human C8orf33 Protein tolerate?

As a general best practice for recombinant proteins, freeze-thaw cycles should be minimized to no more than 2–3 total cycles. Repeated freeze-thaw can significantly reduce protein activity and promote aggregation. It is strongly recommended to aliquot the reconstituted protein into single-use volumes before freezing to avoid this issue.

Is Recombinant Human C8orf33 Protein (rp375832) suitable for use in cell-based assays?

Recombinant Human C8orf33 Protein may be suitable for cell-based functional studies; however, it is essential to verify the endotoxin level from the product's Certificate of Analysis before use, as endotoxin contamination can significantly confound cell-based results. Additionally, confirm that the protein formulation is compatible with your specific cell culture system.

How should I determine the optimal working concentration for my assay?

The optimal working concentration of Recombinant Human C8orf33 Protein should be determined empirically through a dose-response or titration experiment in your specific assay system. Start with a concentration range recommended on the product datasheet if available, and adjust based on observed signal-to-noise ratios and biological responses in your system.

What should I do if the protein does not dissolve completely after reconstitution?

If the protein does not dissolve completely, first ensure you have added a sufficient volume of the appropriate reconstitution buffer. Gently swirl or pipette the solution — do not vortex vigorously — and incubate on ice for an additional 5–10 minutes. If particulates remain, briefly centrifuge at low speed and use the supernatant. Contact Aladdin Scientific technical support if the issue persists.

References

1. Aladdin Scientific. Recombinant Human C8orf33 Protein (rp375832) Product Datasheet and Certificate of Analysis.
2. Wingfield PT. Protein precipitation using ammonium sulfate. Curr Protoc Protein Sci. 2001; Appendix 3:Appendix 3F.
3. Stoscheck CM. Quantitation of protein. Methods Enzymol. 1990;182:50-68.

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.